SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Reducing the risk of transfusion‐transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006
8 references·16 citing·37 second hop
Reducing the risk of transfusion‐transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006 (2007)Reducing the risk of transfusion‐transmis…Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Residual risk of transfusion …The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)The cost‐effectiveness of NAT…Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. (2003)Incidence and estimated rates…Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001 (2003)Estimation of the risk of hep…Safety of the Blood Supply in the United States: Opportunities and Controversies (1997)Safety of the Blood Supply in…Estimates of Infectious Disease Risk Factors in US Blood Donors (1997)Estimates of Infectious Disea…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Human immunodeficiency virus type 1 ‐infected blood donors:behavioral characteristics and reasons for donation (1991)Human immunodeficiency virus …Prevalence and associated risk factors of transfusion transmissible infections among blood donors at Regional Blood Transfusion Center Nakuru and Tenwek Mission Hospital, Kenya (2019)Prevalence and associated ris…Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman (2017)Seroepidemiological Study of …Understanding noncompliance with selective donor deferral criteria for high‐risk behaviors in A ustralian blood donors (2014)Understanding noncompliance w…The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. (2014)The risk of transfusion-trans…Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011. (2014)Changes in frequency of HBV, …Trends in transfusion‐transmissible infections among A ustralian blood donors from 2005 to 2010 (2013)Trends in transfusion‐transmi…Compliance with the current 12‐month deferral for male‐to‐male sex in A ustralia (2013)Compliance with the current 1…Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 2009 (2012)Trends in prevalence, inciden…Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors (2011)Transfusion safety in francop…Surveillance of Transfusion-Transmissible Infections (2011)Surveillance of Transfusion-T…Deferral of males who had sex with other males (2011)Deferral of males who had sex…No evidence of a significantly increased risk of transfusion‐transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12‐month deferral for men who have had sex with men (CME) (2010)No evidence of a significantl…HBsAg, anti-HCV, anti-HIV and VDRL in blood donors: Prevalence and trends in the last three and a half years in a tertiary health care facility in Ile-Ife, Nigeria (2010)HBsAg, anti-HCV, anti-HIV and…Reassessment of deferrals for tattooing and piercing (2009)Reassessment of deferrals for…Epidemiology of hepatitis B in Canadian blood donors (2008)Epidemiology of hepatitis B i…Emerging viral threats to the Australian blood supply (2008)Emerging viral threats to the…The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007 (2009)Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study (2010)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Current risk for transfusion transmitted infections (2007)Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)Informative Dorfman Screening (2011)The social organization of sexuality (1995)Attitudes toward blood donation incentives in the United States: implications for donor recruitment (2003)Effect of a National Disaster on Blood Supply and Safety (2003)First year donation patterns predict long‐term commitment for first‐time donors (2005)Recommendations for Reporting Cost-effectiveness Analyses (1996)Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States (2004)Estimating the cost of blood: past, present, and future directions (2007)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Changing blood donor screening criteria from permanent deferral for men who have sex with men to individual sexual risk assessment: no evidence of a significant impact on the human immunodeficiency virus epidemic in Italy. (2013)Two decades of risk factors and transfusion‐transmissible infections in D utch blood donors (2015)Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. (2009)The blood donor in sub-Saharan Africa: a review (2009)Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years (2010)Sero-prevalence of transfusion-transmittable infections and associated factors among blood donors in Eastern Ethiopia: an Institutional-based cross-sectional study (2019)Safe blood supply in sub-Saharan Africa: challenges and opportunities (2021)Transfusion-Transmitted Infections and associated risk factors at the Northern Zone Blood Transfusion Center in Tanzania: A study of blood donors between 2017 and 2019 (2021)Speaking of Ethnography (1986)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Prevalence of viral markers among first‐time Arab blood donors in Kuwait (2005)Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first‐time blood donors in São Paulo, Brazil (2005)Reducing replacement donors in Sub‐Saharan Africa: challenges and affordability (2007)Karl landsteiner and his major contributions to haematology (2003)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Lessons from Cost-Effectiveness Research for United States Public Health Policy (2007)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
  • 1997Estimates of Infectious Disease Risk Factors in US Blood Donors180 cited
  • 1997Safety of the Blood Supply in the United States: Opportunities and Controversies173 cited
  • 2003Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.126 cited
  • 2003Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001126 cited
  • 2005Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus107 cited
  • 1991Human immunodeficiency virus type 1 ‐infected blood donors:behavioral characteristics and reasons for donation91 cited

Cited by

  • 2019Prevalence and associated risk factors of transfusion transmissible infections among blood donors at Regional Blood Transfusion Center Nakuru and Tenwek Mission Hospital, Kenya63 cited
  • 2010No evidence of a significantly increased risk of transfusion‐transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12‐month deferral for men who have had sex with men (CME)57 cited
  • 2014Understanding noncompliance with selective donor deferral criteria for high‐risk behaviors in A ustralian blood donors48 cited
  • 2011Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

46 cited
  • 2014The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre.43 cited
  • 2011Deferral of males who had sex with other males42 cited
  • 2012Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 200936 cited
  • 2013Compliance with the current 12‐month deferral for male‐to‐male sex in A ustralia36 cited
  • 2013Trends in transfusion‐transmissible infections among A ustralian blood donors from 2005 to 201034 cited
  • 2008Emerging viral threats to the Australian blood supply34 cited
  • 2008Epidemiology of hepatitis B in Canadian blood donors33 cited
  • 2014Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011.33 cited
  • 2009Reassessment of deferrals for tattooing and piercing29 cited
  • 2010HBsAg, anti-HCV, anti-HIV and VDRL in blood donors: Prevalence and trends in the last three and a half years in a tertiary health care facility in Ile-Ife, Nigeria28 cited
  • 2011Surveillance of Transfusion-Transmissible Infections27 cited
  • 2017Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman16 cited